EC Number | Application | Comment | Organism |
---|---|---|---|
1.3.1.9 | medicine | WYW is a potential lead compound for the development of new anti-tuberculosis drugs | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.9 | isoniazid | - |
Mycobacterium tuberculosis | |
1.3.1.9 | WYW | tripeptide inhibitor, identified using a structure-based approach | Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.3.1.9 | Mycobacterium tuberculosis | P9WGR1 | - |
- |
1.3.1.9 | Mycobacterium tuberculosis H37Rv | P9WGR1 | - |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.3.1.9 | enoyl acyl carrier protein reductase | - |
Mycobacterium tuberculosis |
1.3.1.9 | InhA | - |
Mycobacterium tuberculosis |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.3.1.9 | NADH | - |
Mycobacterium tuberculosis |